About this trial
Kinocardiography (KCG) is a portable measurement technique developed to estimate cardiac mechanical performance by studying the vibrations produced by myocardial contraction during each heartbeat and transmitted to the body surface.
The goal of this observational study is to learn about kinocardiography in patients with aortic valve disease (AVD) or thoracic aortic aneurysm (TAA). The investigators believe that this technology will enable to diagnose aortic valve disease and aortic aneurysm.
In patients with AVD of different severities or TAA, the investigators will collect informations from echocardiography and/or cardiac magnetic resonance imaging, KCG recordings, phonocardiography (PCG) recordings, and video recordings. Researchers will also compare subjects without any AVD nor TAA to better understand these effects on KCG, PCG and video signal.
Eligibility criteria
Qualifiers
"Interventional treatment" group
Adults (>18 y)
Interventional treatment indication for severe AVD and/or severe TAA, as decided by the Heart Team
"Aortic valve disease of different severities" group
Disqualifiers
Any severe rhythm disorder such as frequent ventricular extrasystoles, atrial tachyarrhythmias
Subject's disabilty to give consent
Subjects suffering from aortic valve disease or thoracic aortic aneurysm will be excluded from the "control" group.
Trial design
Treatments tested in this trial
- Kinocardiography
Treatment groups
Sponsors and collaborators
Université Libre de Bruxelles
Lead sponsor
Erasme University Hospital
Sponsor institution
Erasme University Hospital
Collaborator